The content is available as a PDF (109.0 KB).
References
- 1.Hornstra G, Barth CA, Galli C, Mensink RP, Mutanen M, Riemersma RA, et al. Br J Nutr. 1998. Functional food science and the cardiovascular system. [DOI] [PubMed] [Google Scholar]
- 2.Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. CMAJ. 2000;163(6):739–44. [PMC free article] [PubMed] [Google Scholar]
- 3.Weinberger MH. Salt and blood pressure. Curr Opin Cardiol. 2000;15(4):254–57. doi: 10.1097/00001573-200007000-00008. [DOI] [PubMed] [Google Scholar]
- 4.Craig WJ. Phytochemicals: Guardians of our health. J Am Diet Assoc. 1997;97(102):S199–204. doi: 10.1016/S0002-8223(97)00765-7. [DOI] [PubMed] [Google Scholar]
- 5.Health Canada, Therapeutic Products Programmethe Food Directorate of the Health Protection Branch. Nutraceuticals/functional foods and health claims on foods policy: Policy paper. 1998. [Google Scholar]
- 6.FoodDrug Administration, US Department of HealthHuman Services. Regulatory impact analysis of the final rules to amend the food labeling regulations. Federal Register. 1993;58:2927–41. [Google Scholar]
- 7.Regulations amending the food and drug regulations (nutrition labeling, nutrition claims and health claims) 2001.
- 8.Health Canada, Bureau of Nutritional Sciences, Food Directorate Branch. Standards of evidence for evaluating foods with health claims: A proposed framework. 2000. [Google Scholar]
- 9.Health Canada, Bureau of Nutritional Sciences, Food Directorate Branch. Chronology of events: Policy development process. 2000. [Google Scholar]
- 10.Health Canada, Bureau of Nutritional Sciences, Food Directorate Branch. Consultation document on generic health claims. 2000. [Google Scholar]
- 11.Health Canada, Bureau of Nutritional Sciences, Food Directorate, Health ProductsFood Branch. Product-specific authorization of health claims for foods: A proposed regulatory framework. 2001. [Google Scholar]
- 12.Stephen AM, Liston AJ, Anthony SP, Munro IC, Anderson GH. Regulation of foods with health claims: A proposal. Can J Public Health. 2002;93(5):328–31. doi: 10.1007/BF03404561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Unnevehr L, Ward MR, Hasler C. Choices First Quarter. 1998. Regulating health claims on food products: The balance between consumer choice and consumer protection; pp. 26–30. [Google Scholar]
- 14.Federal Register. 1997.
- 15.Health Canada. Advisory: Health Canada advises that Becel™ Pro-activ™ not approved for sale. 2001. [Google Scholar]
- 16.Unilever Canada. Unilever Canada Stands Behind Safety of New Becel Pro.activ Margarine. 2001. [Google Scholar]
- 17.Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hyper-cholesterolemic population. N Engl J Med. 1995;333:1308–12. doi: 10.1056/NEJM199511163332002. [DOI] [PubMed] [Google Scholar]
- 18.Jones PJH, Ntanios FY, Raeini-Sarjaz M, Vanstone CA. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr. 1999;69:1144–50. doi: 10.1093/ajcn/69.6.1144. [DOI] [PubMed] [Google Scholar]
- 19.Waalkens-Berendsen DH, Wolterbeek APM, Wijnands MVW, Richold M, Hepburn PA. Safety evaluation of phytosterol esters. Part 3. Two-generation reproduction study in rats with phytosterol esters–a novel functional food. Food Chem Toxicol. 1999;37:683–96. doi: 10.1016/S0278-6915(99)00056-3. [DOI] [PubMed] [Google Scholar]
- 20.Whittaker MH, Frankos VH, Wolterbeek APM, Waalkens-Berendsen DH. Two-generation reproductive toxicity study of plant stanol esters in rats. Regul Toxicol Pharmacol. 1999;29:196–204. doi: 10.1006/rtph.1999.1288. [DOI] [PubMed] [Google Scholar]
- 21.Goldfarb: Consultants for Health Canada, Nutrition Evaluation Division Food Directorate. Health Claims Focus Testing: October 2000. 2000. [Google Scholar]